The QualityStocks Daily Thursday, May 2nd, 2019

Today's Top 3 Investment Newsletters

MarketClub Analysis (DFFN) +91.56%

QualityStocks (CTBO) +66.67%

PoliticsAndMyPortfolio (FTD) +46.67%

The QualityStocks Daily Stock List

Silver Bull Resources, Inc. (SVBL)

Awesome Penny Stocks, Stock Twits, The Street, Simply Wall St, Street Insider, Zacks, Silicon Investor, Proactive Investors, MarketWatch, InvestorsHub, Streetwise Reports, Wallet Investor, Investors Hangout, Wall Street Resources, GuruFocus, Stockhouse, Barchart, TopPennyStockMovers, RedChip, Streetwise Reports, Seeking Alpha, Stock Stars, and Stockopedia reported earlier on Silver Bull Resources, Inc. (SVBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Silver Bull Resources, Inc. is a mineral exploration company based in Vancouver, British Columbia. Its flagship project is called "Sierra Mojada". This Project is 150 kilometers north of the city of Torreon in Coahuila, Mexico. The Project is highly prospective for silver and zinc. An exploration stage enterprise, Silver Bull Resources lists on the OTC Markets Group's OTCQB.

The Sierra Mojada Project is 100 percent owned and operated by the Company. The Project is part of a massive land package comprising 40 mining concessions totaling 21,167 hectares (52,305 acres), situated in an historical high-grade silver, lead, zinc mining district discovered in 1879. Sierra Mojada is an open pittable oxide deposit.

The Sierra Mojada Project has an NI (National Instrument) 43-101 compliant measured and indicated Global resource of 58.7 million tonnes grading at 3.6 percent zinc and 50 g/t silver for 4.670 billion pounds of zinc and 90.8 million ounces of silver. Sierra Mojada has high-quality infrastructure that includes a railway to the site; a paved road; grid power, and five company-owned water wells.

The primary mineralization zone found at Sierra Mojada extends greater than six kilometers in an East-West direction along the base of the Sierra Mojada Range parallel with the Sierra Mojada fault. This area has not been mined with modern mining technology and processes.

Silver Bull Resources earlier acquired a new mineral license in the Palomas Negros area. The prospect lies 9 kilometers to the northwest of the main deposit at Sierra Mojada. The mineral license obtained is a 68 hectare historical mineral license. It had been cancelled for many years by the Mexican mining authorities, and therefore had no official owner. However, it had not been released for staking until recently.

In October 2018, Silver Bull Resources announced an updated NI 43-101 resource on the significant oxide mineralization already defined at Sierra Mojada. Highlights of the resource update include an open pittable, measured and indicated "High Grade Zinc Zone" of 13.5 million tonnes at an average grade of 11.2% Zinc at a 6% cutoff for 3.336 billion pounds of zinc.

Highlights also include an open pittable, measured and indicated "High Grade Silver zone" of 15.2 million tonnes at an average grade of 114.9 g/t at a 50g/t cutoff for 56.3 million ounces of silver. In addition, highlights include Total Measured & Indicated Global Resource of 70.4 million tonnes at 38.6 g/t Ag and 3.4% Zn, which contain 5.354 billion pounds Zn and 87.4 million ounces Ag.

Last month, Silver Bull Resources provided an update on the Sierra Mojada project. The Company announced the forthcoming start of an 8,000 meter surface drill program to target a series of the sulphide extension at depth of the main deposit already defined at Sierra Mojada and a series of never before tested targets within the wider area. Regarding the 2019 Exploration Drill Program, Silver Bull signed a drill contract with Major Drilling De Mexico S.A de C.V to conduct the 8,000 meter drill program initially targeting 4 historic mining areas within the Sierra Mojada property.

Silver Bull Resources, Inc. (SVBL), closed Thursday's trading session at $0.08355, up 1.89%, on 196,499 volume with 21 trades. The average volume for the last 3 months is 168,027 and the stock's 52-week low/high is $0.075/$0.159.

chart

Cantabio Pharmaceuticals, Inc. (CTBO)

Profitable Trader Authority, HotStockProfits, Profitable Trading, Leeb's Market Forecast, AwesomeStocks, OTCtipReporter, Investors Alley and PennyStockScholar reported previously on Cantabio Pharmaceuticals, Inc. (CTBO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cantabio Pharmaceuticals, Inc. centers on bringing novel, first-in-class drug candidates into clinical trials and beyond. The Company does so through the discovery and development of ground-breaking pharmacological chaperone and protein delivery based therapeutics, focusing on protein systems implicated in neurodegenerative disorders. These include Alzheimer's, Parkinson's, and oxidative stress. At present, Cantabio is engaging in advanced pre-clinical trials of its therapeutic candidates and is focused on developing these towards clinical trials. A preclinical stage biotechnology company, Cantabio Pharmaceuticals is headquartered in Sunnyvale, California.

The Company is concentrating on commercializing novel therapies and the Intellectual Property (IP) produced from its research and development (R&D) activities for Parkinson's disease (PD), Alzheimer's disease (AD), and other related neurodegenerative diseases. Cantabio's strategy combines a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach.

In addition, Cantabio is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins, which display loss of function during disease conditions. The Company has a new preclinical therapeutic program for Alzheimer's disease that it is pursuing through its drug discovery partnership with NovAliX. The program is targeted at the development of small molecule chaperones that stabilize the Abeta peptide, the aggregation of which is considered to be a vital element in the onset and progression of Alzheimer's disease.

This week, Cantabio Pharmaceuticals' Dr. Gergely Toth, the Company's Chief Executive Officer, presented the latest results from Cantabio's DJ-1 protein targeting small molecule pharmacological chaperone therapeutic program at the Milner Therapeutics Symposium on October 1, 2018. The Symposium is a key networking event for drug discovery professionals and Milner Therapeutics Institute alliance partners that includes companies such as AstraZeneca, GlaxoSmithKline, Shionogi, Pfizer and Johnson and Johnson.

DJ-1 is a novel and crucial target for the treatment of several conditions, as loss of DJ-1 protein function has been linked to the onset of an array of diseases including Parkinson's disease, Alzheimer's disease, stroke, amyotrophic lateral sclerosis, chronic obstructive pulmonary disease and type II diabetes. The DJ-1 protein is considered to be one of the chief therapeutic targets for Parkinson's disease, as it is genetically linked to the onset of familial Parkinson's.

Cantabio Pharmaceuticals, Inc. (CTBO), closed Thursday's trading session at $0.01, up 66.67%, on 24,200 volume with 5 trades. The average volume for the last 3 months is 340,156 and the stock's 52-week low/high is $0.002/$0.10.

chart

Patriot Gold Corp. (PGOL)

Investopedia, The Street, Proactive Investors, Stockwatch, Barchart, Dividend Investor, YCharts, Wallet Investor, Real Pennies, OtcWizard, Standout Stocks, Marketwired, and Gold Investment Letter reported beforehand on Patriot Gold Corp. (PGOL), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company listed on the OTC Markets' OTCQB. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. Currently, the Company holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is based in Las Vegas, Nevada.

The Company holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Windy Peak and Vernal projects in Nevada. The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. is the owner of the Moss Mine. The Moss Mine entered commercial production as of the beginning of September 2018.

The Vernal gold project is in its early stage. This property is approximately 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. This property comprises 12 unpatented mining claims (240 acres).

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is about 45 miles southeast of Fallon and 6 miles from Middlegate.

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is approximately 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Canamex Resources Corp. is the owner of the Bruner gold project.

The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and current reserves) and the Comstock (more than 8 million ounces).

This month, Patriot Gold announced that it completed an initial phase of drilling exploration at the Windy Peak Project in Churchill County, Nevada, beginning in September 2018. At present, the Windy Peak deposit is interpreted as a low-sulfidation, epithermal gold deposit positioned marginal to and likely associated with a caldera ring fracture zone.

Intersections between ring fractures and regional normal faults in the Windy Peak Project area are especially favorable exploration targets. They offer the unique combination of fluid conduits and structural controls known to concentrate high-grade mineralization.

Patriot Gold Corp. (PGOL), closed Thursday's trading session at $0.06576, up 5.55%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 19,097 and the stock's 52-week low/high is $0.0438/$0.15.

chart

Avita Medical Limited (AVMXY)

Hot Copper, Speculating Stocks, InvestorsHub, MarketWatch, Stockhouse, Stock Invest, Street Insider, The StreetWise Reports, Marketbeat, OTC Markets, The Street, Penny Stock Picks, Zacks, Trading View, Edison Investment Research, Marketwired, Business Insider, GuruFocus, Wallet Investor, 4-Traders and Amigo Bulls reported earlier on Avita Medical Limited (AVMXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Avita Medical Limited provides an inventive approach to skin regeneration. The Company's products are for the treatment of a broad array of wounds, scars, and skin defects. These products are presently available directly in the United Kingdom (UK), Germany, Australia and New Zealand and worldwide through distributors in France, Belgium, the Netherlands, Turkey, China, Malaysia, Taiwan, Iran and South Africa.

A medical device company and OTCQX-listed, Avita Medical operates from offices in Wimbledon, UK; Valencia, California, and Perth, Australia. PM360, a foremost trade magazine for marketing decision makers in the pharmaceutical, biotechnology, medical device, and diagnostics industries, named Avita Medical as one of the most innovative companies of 2018.

Avita Medical's portfolio (in all countries outside of Europe) is marketed under the ReCell® brand to promote skin healing in a wide assortment of applications. These include burns, chronic wounds, and aesthetics. In the U.S, ReCell® is an investigational device limited by federal law to investigational and compassionate use.

The Company's patented and proprietary collection and application technology provides unique treatment solutions derived from the regenerative properties of a patient's own skin. Avita's medical devices work by preparing a Regenerative Epithelial Suspension (RES™). This is an autologous suspension consisting of the patients' own skin cells and wound healing factors that are essential to regenerate natural healthy skin. This is subsequently applied to the area to undergo treatment.

Avita Medical's portfolio of medical device products received CE-mark approval in Europe as three tailored product presentations, with three individual brand names. These are ReCell®, ReGenerCell™, and ReNovaCell™. The design of ReCell® is for the treatment of burns and plastic reconstructive procedures. ReGenerCell™ has been formulated for chronic wounds. This includes leg and foot ulcers. ReNovaCell™ is tailored for aesthetic applications, which includes pigmentation restoration.

Avita Medical announced this past January that it began the U.S. national market launch of the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of acute thermal burns in patients 18 years and older. The U.S. sales team of Regenerative Tissue Specialists and Clinical Training Specialists, which joined AVITA Medical in November 2018, have been trained and were fully deployed throughout the U.S. in support of the nationwide launch of the RECELL System.

Earlier this month, AVITA Medical announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of burns and other wounds in Japan. COSMOTEC filed on February 25, 2019 a Japan's Pharmaceuticals and Medical Devices Act (JPMDA) application for approval to market the RECELL System in Japan. The JPMDA has accepted the application. The expectation is that the review will take nine months to a year.

Avita Medical Limited (AVMXY), closed Thursday's trading session at $5.09, up 6.26%, on 344,067 volume with 316 trades. The average volume for the last 3 months is 419,852 and the stock's 52-week low/high is $0.77/$7.67.

chart

LiCo Energy Metals, Inc. (WCTXF)

Penny Stock Hub, SmallCapVoice, Metals News, Market Screener, Streetwise Reports, OTC Markets, Dividend Investor, Emerging Growth, Stockhouse, InvestorsHub, Barchart, MarketWatch, and Stock of the Week reported previously on LiCo Energy Metals, Inc. (WCTXF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1998, LiCo Energy Metals, Inc. conducts exploration for metals used in the production of lithium-ion batteries. The Company has four ongoing projects in mining-friendly jurisdictions within the United States, Canada, and Chile. It has a growing portfolio of promising projects, all with goals of developing battery-grade lithium or cobalt.

LiCo Energy Metals is based in Vancouver, British Columbia. The Company lists on the OTC Markets' OTCQB. The Company previously went by the name Wildcat Exploration Ltd. It changed its name to LiCo Energy Metals, Inc. in October of 2016.

LiCo's projects include the Glencore Bucke Property, the Teledyne Cobalt Project, the Dixie Valley Lithium Project, and the Black Rock Desert Lithium Project. The Glencore property consists of 16.2 hectares. It sits along the west boundary of the Company's Teledyne Cobalt Project.

The Teledyne Cobalt Project comprises 5 mining claims and 6 staked crown claims in the Buck and Lorrain Townships, in the district of Temiskaming, Ontario. This project covers 115.5 hectares of mining and surface rights, with an additional 439.1 hectares of staked crown claims.

LiCo Energy Metals previously entered into an option to acquire 100 percent, Net 3 Percent Smelter royalty to acquire 348 claims in the Dixie Valley Exploration Project in Churchill County, Nevada. Moreover, it entered into an option agreement where it may earn an undivided 100 percent interest subject to a 3 percent Net Smelter Return Royalty in the existing Black Rock Desert Lithium Project. This Project consists of 199 placer claims (3,980 acres/1,610 hectares) in southwest Black Rock Desert, Washoe County, Nevada.

LiCo Energy Metals entered into an Option Agreement with Surge Exploration, Inc. Surge can earn an undivided 60 percent interest in the Glencore Bucke and the Teledyne Cobalt Properties in Cobalt Ontario, subject to certain cash, share and exploration payments to LiCo. Upon Surge having exercised the Option, Surge Exploration will have earned an undivided 60 percent interest in the Cobalt Properties. Also, the parties will enter into a Commercially Reasonable and Definitive Joint Venture Agreement.

Last month, LiCo Energy Metals provided interim assay results from drill holes GB18-22 to GB18-30, drilled on its Glencore Bucke Cobalt Property (Cobalt, Ontario). During the late fall of 2018, LiCo completed 4,272 m/14,016 ft. of diamond drilling in 33 holes on the Glencore-Bucke and Teledyne Cobalt Properties: 2,559 m/8,396 ft. were completed in 24 drill holes on the Glencore Bucke Property, and 1,713 m/5,620 ft. in 9 drill holes on the Teledyne Cobalt Property.

On the Glencore-Bucke Property, drill holes GB18-22 to GB18-30 tested the Northwest and Main Zones with the aim of intersecting mineralized zones along strike and vertically above and below prior intersections reported in LiCo's 2017 drilling program on the same properties. Highlights from diamond drill holes GB18-22 to GB18-30 include GB18-26 0.29 % Co over 0.25 m from 79.25 to 79.50 m; and GB18-27 0.47 % Co, 33.1 ppm Ag, 0.82% Cu over 2.33 m from 94.42 to 96.75 m, including 1.3% Co, 65.8 ppm Ag, 0.97% Cu over 0.83 m from 94.42 to 95.25 m.

Highlights also include GB18-29 1.28% Cu over 3.75 m from 61.75 to 65.50 m, including 0.24% Co, 0.43% Cu from 63.00 to 63.40 m, and GB18-30 0.70 % Co over 0.50 m from 40.00 to 40.50 m. In addition, there were no significant results for drill hole GB18-22.

LiCo Energy Metals, Inc. (WCTXF), closed Thursday's trading session at $0.075, up 9.97%, on 2,100 volume with 4 trades. The average volume for the last 3 months is 12,416 and the stock's 52-week low/high is $0.014/$0.18.

chart

Vitalibis, Inc. (VCBD)

Dividend Investor, InvestorsHub, Wallet Investor, Simply Wall St, Morningstar, Investors Hangout, TradingView, 4-Traders, Stockopedia, Stockflare, Stockwatch, Stockhouse, OTC Markets, Market Exclusive, Seeking Alpha, GlobeNewswire, GuruFocus, Barchart, Street Insider, and MarketWatch reported previously on Vitalibis, Inc. (VCBD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vitalibis, Inc. is a technology-based seller of premium, full spectrum phyto-cannabinoid rich (PCR) products. In addition, the Company is a seller of personal care and organic certified nutritional products formulated with first-class hemp extracts. Vitalibis is working to be an iconic lifestyle brand that promotes health and wellness within the fast-growing medicinal cannabis industry. Vitalibis is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.

Vitalibis' emphasis is selling branded, full spectrum, phyto-cannabinoid rich hemp oil products, cold processed skincare, body care and organic certified nutritional products that are safe and effective. All of its products are made using cold-processed technology, to minimize heat and harmful ingredients.

Concerning its products, the Company's Vitalibis Signature 300 is a full spectrum, phyto-cannabinoid rich (PCR) hemp oil blended with Medium Chain Triglycerides (MCT) from coconut oil. Additionally, its Vitalibis Daily Wellness capsules are a certified organic super-food specifically formulated to promote overall wellness and balanced health.

Vitalibis has a technology integration agreement to license the state-of-the-art newkleus™ technology to facilitate its micro-influencer sales model and enhance and complement its social media strategy. This agreement grants Vitalibis an exclusive license for the newkleus patent-pending, user-generated content (UGC) technology for all applications in the cannabis industry.

Vitalibis recently launched its newest product, the Vitalibis Soothing Body Cream. The Vitalibis Soothing Body Cream contains several oils, which provide a cooling/warming sensation to targeted areas. It does so while leaving the skin feeling moisturized.

Vitalibis announced this past January that it entered into a Business Alliance Agreement with Aromatics International. Vitalibis will market and sell certain Aromatics International essential oil products within a newly launched Curated Products section of the Vitalibis website.

Also in January, Vitalibis announced that it signed an alliance agreement with iconic cultural brand Bruce Lee Beverage, LLC. This alliance agreement is for the development, marketing, and distribution of a Bruce Lee branded, Vitalibis Signature 900+ oil.

Vitalibis and Bruce Lee Beverage will work together to launch a proprietary full spectrum phytocannabinoid rich hemp oil with 900mg of naturally occurring cannabidiol (CBD) per bottle. Moreover, the Signature 900+ oil will include a proprietary blend of natural herbs and ingredients inspired by Bruce Lee's health and wellness practice.

Last month, Vitalibis announced the appointment of Oran Arazi-Gamliel to the Company's Advisory Board.  Arazi-Gamliel has wide-ranging experience in the fields of wellness, direct selling, as well as international commercial strategies. Arazi-Gamliel serves as an advisor to Chief Execeutive Officers, Investment Banks and Strategy Consulting Firms, and holds an MBA in International Business.

Vitalibis, Inc. (VCBD), closed Thursday's trading session at $1.06, up 0.95%, on 708 volume with 10 trades. The average volume for the last 3 months is 8,421 and the stock's 52-week low/high is $0.55/$4.91.

chart

Atico Mining Corporation (ATCMF)

Junior Mining Network, OTC Markets, The Northern Miner, 4-Traders, Stockhouse, Marketwired, MarketWatch, InvestorsHub, Capital Cube, Streetwise Reports, Investing News, Barchart, and The Street reported previously on Atico Mining Corporation (ATCMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Atico Mining Corporation centers on exploring, developing, and mining copper and gold projects in Latin America. The Company focuses on developing and operating high margin midsized Cu-Au deposits. It has a proven team of mine developers and mine operators. Atico's chief project is the El Roble mine in Colombia. Atico Mining is based in Vancouver, British Columbia and lists on the OTC Markets.

Atico is in production and producing cash flow at the El Roble mine. El Roble is in Carmen De Atrato, Colombia. El Roble is a 6,679-hectare project and is a producing mine with an 800 tonnes per day throughput capacity. The end product is CU (+AU, AG) concentrate. The deposit type is Mafic-Type Volcanic Massive Sulphide. Atico's ownership of El Roble is 90 percent of the operating mine and surrounding claims.

Prior evaluations by Atico Mining identified high-grade mineralization below the lowest production levels at El Roble. These evaluations also defined a measured and indicated resource of 1.86 million tonnes grading 3.46 percent copper and 2.27 g/t gold.

On the larger land package, Atico has identified a prospective stratigraphic contact between volcanic rocks and black and grey pelagic sediments and cherts. This has been traced by Atico geologists for 10 kilometers. This contact has been determined to be an important control on VMS mineralization on which the Company has identified many target areas prospective for VMS type mineralization occurrence, which is the emphasis of the present surface drill program at El Roble.

This past January, Atico Mining announced operating results for the three and twelve month periods ended December 31, 2018 from its El Roble mine. Production totaled 5.81 million pounds of copper with 2,913 ounces of gold for Q4 2018 and 21.87 million pounds of copper with 11,344 ounces of gold in concentrates for the full year 2018.

Mr. Fernando E. Ganoza, Chief Executive Officer, said, "Atico has successfully concluded its fifth full year of operating the El Roble mine, exceeding most of the 2018 guidance while achieving the highest annual production results to date. In the upcoming year, we will continue aggressive exploration at the El Roble property with an intensified focus on the prospective 6,400-hectare land package while working towards achieving stated guidance."

Atico Mining Corporation (ATCMF), closed Thursday's trading session at $0.22, up 0.92%, on 24,400 volume with 12 trades. The average volume for the last 3 months is 16,591 and the stock's 52-week low/high is $0.1681/$0.50.

chart

All For One Media Corp. (AFOM)

OTC Markets, MarketWatch, Global Energy Media, Central Charts, Simply Wall St, Pink Investing, Stock Digest, Penny Stock Tweets, Street Register, Stockhouse, Financial Content, Emerging Growth, The Street, Market Exclusive, InvestorsHub, Capital Network, Proactive Investors, and Barchart reported earlier on All For One Media Corp. (AFOM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

All For One Media Corp. is a tween marketing company listed on the OTC Markets' OTCQB. Named "Generation I" for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All For One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. All For One Media has its head office in Mount Kisco, New York.

The Company is working to make the transition from a development stage corporation creating and acquiring media assets to a content provider launching many initiatives marketed to its core tween demographic. Its goal is to capitalize on a broad variety of potential revenue streams.

All For One Media, through entertainment, is working to deliver a message that will resonate with kids to impact the epidemic of bullying and cyber-bullying. In addition, it is working to help individuals who have been affected by bullying to deal with it in a positive and constructive manner.  

All For One Media has produced Drama Drama (f/k/a "Crazy For the Boys"). Drama Drama is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. This film tells the story of five high school girls from five very different cliques who must work together to run their school's anti-bullying organization. The film features original pop songs pertaining to peer pressure, unrequited love, and teen angst. The expectation is that Drama Drama will generate revenues from numerous sources.

The Company has completed production of Drama Drama. It has started to screen the movie for buyers. Moreover, it engaged William Morris/Endeavor Content (WME) as the exclusive sales agent for the film. WME represents artists across all media platforms, particularly movies, television, music, theatre, digital and publishing.

All for One Media is making plans to commence group activities for the launch of the band "Drama Drama" concurrent to the release of the movie. The release of a full-length film used to promote the launch of a pop group is an industry first. The Company has also started negotiations with a number of major record labels for distribution of the film soundtrack.

All For One Media Corp. (AFOM), closed Thursday's trading session at $0.022, up 16.71%, on 230,700 volume with 14 trades. The average volume for the last 3 months is 101,481 and the stock's 52-week low/high is $0.01051/$0.225.

chart

Aurion Resources Ltd. (AIRRF)

Gold Stock Data, MoneyHub, Stockwatch, Barchart, The Street, Wallmine, Gold Telegraph, Market Screener, Stockscores, Investor Point, Penny Stock Hub, Stockhouse, Investors Guru, Dividend Investor, Wallet Investor, and 4-Traders reported previously on Aurion Resources Ltd. (AIRRF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Aurion Resources Ltd. is an exploration company with a strategy to generate or acquire early stage precious metals exploration opportunities and advance them via business partnerships or joint venture (JV) arrangements. Incorporated in 2006, Aurion Resources is headquartered in St. John's, NL (Newfoundland and Labrador). The Company lists on the OTC Markets.

At present, the Company's focus is on developing its projects in Finland where it has a JV arrangement with B2 Gold Corp. In 2014, Aurion Resources started a gold exploration initiative in the Central Lapland Greenstone Belt (CLGB) of Northern Finland. The Company controls around 200,000 ha of mineral tenements within the Paleoproterozoic, CLGB.

Aurion Resources' first acquisition was the purchase of the Kutuvuoma and Silasselka projects from Dragon Mining Oy. Subsequently, the Company independently acquired more mineral tenements throughout the CLGB. Current total land holdings are now roughly 70,000 hectares.

Kutuvuoma is a high-grade gold project. Kutuvuoma occurs along a multi-km structural-stratigraphic trend associated with the regional Sirkka Shear Zone. In the 1960s, Silasselka was discovered by the State mining entity Otanmaki Oy. Silasselka lies north of and along trend with the Hanhimaa Shear Zone, which hosts many gold occurrences to the south. No exploration has taken place since the 1960s. In addition, no gold exploration is documented.

Last month, Aurion Resources reported on the recent discovery of widespread gold mineralization at its 100 percent owned Launi East Project in northern Finland. Selected highlights include 399 rock samples collected over a 2.0 km² area average 2.47 g/t Au. There is local visible gold in rocks assaying up to 379.0 g/t Au. Individual veins can be traced for greater than 100 m in bedrock.

Mr. Mike Basha, Aurion Resources' President and Chief Executive Officer, said, "The discovery of new gold mineralization in another area with no history of mineral exploration again demonstrates how underexplored the Central Lapland Greenstone Belt and the Sirkka Shear Zone are. It is very early days at Launi.  We look forward to advancing Launi further during the upcoming field season." 

Last week, Aurion Resources provided an update on the recently completed 12,000 m drilling campaign at the Aamurusko and Notches prospects on its Risti Project in northern Finland. Selected highlights include new near-surface gold intercepts extending Aamurusko mineralized shoot to 100 m strike. Highlights also include 23.40 g/t Au over 0.50 m intersected in drill hole AM19080 at Aamuursko. Moreover, highlights include 24.80 g/t Au over 0.50 m intersected in drill hole AM19088 at Aamurusko.

Additionally, mineralized gold-bearing conglomerate was encountered in drilling at Notches, and 20.30 g/t Au over 0.65 m was intersected in drill hole NT18006 at Notches. Furthermore, significant core loss was experienced in a number of holes at Aamurusko.

Aurion Resources Ltd. (AIRRF), closed Thursday's trading session at $1.00, up 33.37%, on 300 volume with 1 trade. The average volume for the last 3 months is 10,381 and the stock's 52-week low/high is $0.516/$1.63.

chart

Elev8 Brands, Inc. (VATE)

Stockwatch, InvestorsHub, MarketWatch, GuruFocus, Stockhouse, Investors Hangout, The Street, Dividend Investor, Penny Stock Hub, Penny Stock Tweets, Investor Place, Otc.Watch, Wallet Investor, Market Screener, YCharts, Barchart, and Insider Financial reported previously on Elev8 Brands, Inc. (VATE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Elev8 Brands, Inc. is a holding company centered on the commercial development of hemp and CBD-based products. It specializes in the development and marketing of products for the fitness and wellness markets. Elev8 Brands is founded based on creating high-quality, sustainable products for health-conscious consumers. Zoe CBD is a wholly-owned subsidiary of the Company. Elev8 Brands is based in Florida and the Company lists on the OTC Markets' OTCQB.

Elev8 Brands' Zoe CBD subsidiary concentrates on the development and marketing of CBD-based products. These include CBD Tinctures, CBD E-Juice, CBD Lotion, as well as CBD Salve. In October of 2018, Canbiola, Inc. announced that it signed a manufacturing and supply agreement with Elev8 Brands for the manufacturing of its new Zoe CBD CryoGel. Canbiola is a manufacturer of proprietary CBD non-psychoactive cannabinoid products extracted from the hemp plant.

The all-new CryoGel is an all-natural gel. It helps to relieve pain. In addition, it is Vegan, Non-GMO, Non-GE, and made with all-natural and organic components. CryoGel is a quick-acting all-natural infused product that is 99.9 percent pure CBD.

The first flavor of Elev8 Hemp's New CBD Iced Tea will be Lemon. The Company's mission is to introduce CBD to consumers via premium everyday consumable products. Elev8 Brands currently has product in more than 60 locations nationwide.

Last week, Elev8 Brands released the official March 15, 2019 launch date of its Ready to Drink (RTD) Cannabinoid (CBD) Lemon Iced Tea. Mr. Ryan Medico, Elev8 Brands' Chief Executive Officer, said, "It's amazing watching a vision come to fruition. Our brand stands out among the best and we can't wait for our customers to get their hands on these new RTD CBD infused beverages. With demand so high, our team already has samples in hand, from formulators, for a peach tea, hibiscus green tea and a raspberry tea."

Elev8 Brands, Inc. (VATE), closed Thursday's trading session at $0.029, up 0.69%, on 1,200,729 volume with 64 trades. The average volume for the last 3 months is 3,863,042 and the stock's 52-week low/high is $0.0262/$0.0779.

chart

Leatt Corporation (LEAT)

Penny Stock Hub, Valuespectrum, Stockwatch, Market News Desk, InvestorsHub, Wallet Investor, GuruFocus, Dividend Investor, MarketWatch, GlobeNewswire, Stockhouse, Stockopedia, Trading View, Seeking Alpha, OTC Markets, and Interactive Brokers reported earlier on Leatt Corporation (LEAT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Leatt Corporation is a foremost developer and marketer of protective equipment and ancillary products. These are for a broad array of sports, particularly extreme high-velocity sports. Its products are used by riders of motorcycles, bicycles, snowmobiles, and ATVs, and also racing car drivers. The Company sells its products to customers via a network of distributors and retailers; and through its online store. Leatt Corporation is based in South Africa. It has warehouses and a distribution office in California for the North American Market.

The Leatt-Brace® is an award-winning neck brace system. It is considered the gold standard for neck protection for anyone wearing a crash helmet as a type of protection. The design of it was for participants in action sports or riding motorcycles, bicycles, all-terrain vehicles, snowmobiles and other vehicles.

Additionally, Leatt provides the Leatt helmet range for head and brain protection; and the Leatt body armor range, including chest protectors, body protectors, back protectors, elbow guards, shoulder braces, knee braces, knee and leg guards, kidney belts, and impact shorts. It also offers Leatt the apparel range consisting of gloves, riding jackets, jerseys, bicycle shorts and pants, and off-road pants.

Moreover, it offers casual clothing and socks; and other products, parts, and accessories. These include toolbelt bags, duffel bags, gear bags, helmet bags, and hats and hydration kits. Additionally, the Company provides aftermarket support services. It also acts as the original equipment manufacturer (OEM) for neck braces sold by other brands.

This past January, Leatt Corporation announced the official launch of its new Z-Frame knee brace. The Z-Frame was engineered to help lessen knee forces. It limits knee injuries and is CE certified as a medical and impact protection device. The Z-frame is made of an injected composite chassis with slim hinges for a premier bike feel. The knee brace is available in sizes S-XL.

For Full-Year 2018, Leatt had record Revenues of $24.4 million. This was up $4.25 million or 21 percent, versus 2017. Net Income rose 404 percent to $1.2 million, or $0.22 per diluted share, versus $237,000, or $0.04 per diluted share, in 2017. The Company's Total Operating Expenses increased 8 percent, while Revenues grew by 21 percent. Income from Operations was $1.5 million, versus $226,000 in 2017.

Leatt Corporation (LEAT), closed Thursday's trading session at $2.25, up 2.09%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 1,650 and the stock's 52-week low/high is $0.67/$3.29.

chart

Natural Health Farm Holdings, Inc. (NHEL)

Stockopedia, Stockhouse, Market Exclusive, Capital Cube, 4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Last10k, and Barchart reported earlier on Natural Health Farm Holdings, Inc. (NHEL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natural Health Farm Holdings, Inc. is a biotechnology company working to establish a complete healthcare one-stop shop based on natural or naturopathic products. Since November of 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of various diseases and nutritional consulting services. Natural Health Farm Holdings is headquartered in Las Vegas, Nevada. The Company lists on the OTCQB.

Natural Health Farm provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. The Company's principal activities are in retailing nutritional supplements, organic foods and health-care related products.

Via its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of numerous retail & franchise outlets throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.

Natural Health Farm Holdings announced this past January that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With the agreement, Natural Health Farm shall acquire 100 percent of Natural Tech R&D's outstanding shares for USD 1 Million.

Natural Health Farm Holdings also announced in January that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements business in Malaysia.

Last month, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Health Naturopathic Academy Sdn Bhd (NHNA), a Malaysian healthcare education provider. Natural Health Naturopathic Academy offers courses on health, nutrition, dietetic and Chinese & natural medicine, which are accredited by over 30 countries.

Earlier this month, Natural Health Farm Holdings announced that it executed a term sheet to acquire a majority equity interest in Biodelta (Pty) Ltd. Biodelta is a contract developer and manufacturer of nutraceutical products in South Africa. Furthermore, this month, the Company announced that it executed an agreement to acquire all the issued and outstanding shares of Natural Health Farm, Inc. (NHF). NHF is a distributor of naturopathic and nutraceutical products in North Carolina and throughout the East Coast of the United States.

Natural Health Farm Holdings, Inc. (NHEL), closed Thursday's trading session at $0.175, up 9.38%, on 28,542 volume with 12 trades. The average volume for the last 3 months is 311,986 and the stock's 52-week low/high is $0.155/$6.00.

chart

Grayscale Bitcoin Trust (GBTC)

Bitcoinist, Morningstar, MarketWatch, CryptoNinjas, Bitcoin Exchange Guide, Zacks, Dividend Investor, Marketbeat, Crypto Currency Facts, YCharts, Investors.com, The Street, Trading View, Investopedia, and InvestorsHub reported previously on Grayscale Bitcoin Trust (GBTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Grayscale Investments, LLC, with its Grayscale Bitcoin Trust is the world's largest digital currency asset manager. The Company gives investors the tools to make informed investing decisions in a growing asset class. Grayscale Bitcoin Trust™ (GBTC) and Grayscale Ethereum Classic Trust™ (ETCG) are publicly quoted and available to all individual and institutional investors on the aforementioned OTCQX® Best Market. Grayscale Investments is based in New York, New York.

The Company is a wholly-owned subsidiary of the Digital Currency Group. The Digital Currency Group builds, buys, and invests in greater than 130 bitcoin and blockchain companies globally. Grayscale accesses the world's largest network of digital currency intelligence to build better investment products. It has removed the barrier to entry so that institutions and investors can benefit from exposure to digital currencies. Grayscale provides secure access and diversified exposure to the digital currency asset class.

This past January, Grayscale Investments announced it launched Grayscale Stellar Lumens Trust. This is the first single-asset investment product that provides exposure to Lumens (XLM), which is the native asset of the Stellar network. This is the ninth single-asset investment product introduced by Grayscale Investments.

The Stellar platform connects financial institutions, payment systems, and people worldwide. Lumens is the native asset of the Stellar network that allows users to move money worldwide and conduct transactions between different currencies fast and securely. 

Grayscale also manages Grayscale Digital Large Cap Fund™. This is a diversified investment product that provides exposure to the leading digital currencies by market capitalization. Grayscale sponsors single-asset investment products. These provide exposure to Bitcoin (BTC), Bitcoin Cash (BCH), Ethereum (ETH), Ethereum Classic (ETC), Horizen (ZEN), Litecoin (LTC), XRP, and Zcash (ZEC).

Furthermore, Grayscale announced changes to the names of its single-asset products. These products will now be named Grayscale Bitcoin Trust™;
Grayscale Bitcoin Cash Trust™; Grayscale Ethereum Trust™; Grayscale Ethereum Classic Trust™; Grayscale Horizen Trust™; Grayscale Litecoin Trust™; Grayscale Stellar Lumens Trust™; Grayscale XRP Trust™, and
Grayscale Zcash Trust™.

Grayscale Bitcoin Trust (GBTC), closed Thursday's trading session at $6.85, up 1.48%, on 2,695,947 volume with 3,379 trades. The average volume for the last 3 months is 2,882,837 and the stock's 52-week low/high is $3.66/$15.69.

chart

Driven Deliveries, Inc. (DRVD)

Invest Tribune, Stock Price, Dividend Investor, GlobeNewswire, InvestorsHub, MarketWatch, Barchart, Seeking Alpha, Trading View, Last10k, Stockopedia, Simply Wall St, Stockhouse, Investors Hangout, Market Screener, Stockwatch, Financial Buzz, Research Pool, and Business Insider reported earlier on Driven Deliveries, Inc. (DRVD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2013, Driven Deliveries, Inc. is the world's first and only publicly traded cannabis delivery company. It provides delivery services of legal cannabis products to consumers in the State of California. The Company previously went by the name Results-Based Outsourcing, Inc. It changed its name to Driven Deliveries, Inc. in September of 2018. The Company is based in San Diego, California.

Driven Deliveries' focus is turn key delivery solutions for licensed brands and dispensaries. The Company provides legal cannabis consumers the ability to purchase and receive their marijuana in a quick and convenient way. It provides on-demand marijuana delivery, in select cities where permitted by law.

Company Management believes it is uniquely positioned to best serve the needs of the developing cannabis industry and capture significant market share within the sector. Experienced technology and cannabis executives founded Driven Deliveries.

Last month, Driven Deliveries announced the launch of its new delivery model, Driven Direct. This will allow the Company to work directly with brands and retailers to deliver a wide spectrum of cannabis products directly to consumers. The Company will be launching with manifold retail partners in California. In addition, Driven Deliveries will offer delivery throughout the state encompassing major metro centers and the majority of the population.

Driven Direct's structure will be similar to that of Amazon's delivery model. The design of program is to enable entrepreneurs to run their own local delivery networks featuring the Driven Deliveries logos.

Each delivery unit will start its day at a designated Driven station in California. There, packages ordered from local retailers are subsequently picked up by Driven Deliveries drivers and delivered direct to the consumer. Location-based algorithms will ascertain which packages are sent to these delivery stations.

Today, Driven Deliveries announced that it has partnered with BLAZE, Inc. to provide a full-service technology platform for advertising, point-of-sale, customer interfacing and more. BLAZE is a foremost compliance technology platform in the cannabis industry. It has greater than 100 clients in 4 states and will be working with Driven Deliveries for cross referral opportunities for both businesses.

Driven Deliveries, Inc. (DRVD), closed Thursday's trading session at $1.75, up 4.17%, on 91,002 volume with 62 trades. The average volume for the last 3 months is 11,876 and the stock's 52-week low/high is $0.024/$5.85.

chart

The QualityStocks Company Corner

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP) ("DVLP" or the "Company"), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is proud to announce that it has now obtained fully-audited fully-reporting status with the SEC following the filing of audited financial data along with Form 10. In addition, the Company is in the process of uplisting shares from the Pink Sheets onto the OTCQB "Venture Market" tier.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.02275, up 42.19%, on 10,176,695 volume with 432 trades. The average volume for the last 3 months is 3,976,404 and the stock's 52-week low/high is $0.012/$0.14.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN), a premium cannabis firm, recently added one of North America's leading CBD processing labs to its portfolio through the acquisition of Coastal Labs (http://nnw.fm/X1j30). To view the full article, visit: http://nnw.fm/DksT9.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.72, up 1.41%, on 7,346 volume with 9 trades. The average volume for the last 3 months is 27,762 and the stock's 52-week low/high is $0.07/$0.722.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Leading California edibles manufacturer Plus Products (CSE: PLUS) (OTCQB: PLPRF) on Wednesday released the company's audited financials for the quarter ended and calendar year ended December 31, 2018. According to the update, revenue growth, reported in USD, was reflected in annual revenues that soared to $8.4 million in 2018, reflecting a 681 percent increase over 2017 revenues of $1.1 million. To view the full press release, visit: http://nnw.fm/R0dmE. Also today, the company was highlighted in the 420 with CNW by CannabisNewsWire.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.6215, up 5.89%, on 132,058 volume with 178 trades. The average volume for the last 3 months is 84,013 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) recently reported that positive preclinical data for the combination of the TUSC2 gene with an anti-PD1 antibody was recorded by its University of Texas MD Anderson Cancer Center collaborators in a lung cancer treatment study (http://nnw.fm/8E4bC). To view the full article, visit: http://nnw.fm/42wJC.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.75, even for the day, on 7,716 volume with 28 trades. The average volume for the last 3 months is 48,139 and the stock's 52-week low/high is $0.95/$18.44.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (Redfund or the "Company") is pleased to announce the signing of a promissory note between the Company and the Cannabis Mercantile Exchange ("Cannamerx"), one of the first cannabis and hemp auction platforms to go live. The Company's intention is to finance the Cannamerx business model and build their global footprint of clientele. Also today, the company was highlighted in the 420 with CNW by CannabisNewsWire.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (OTCQB: PNNRF), closed the day's trading session at $0.131, even for the day, on 10 volume with 1 trade. The average volume for the last 3 months is 511 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has successfully negotiated new three-year compensation contracts with key officers Chris Bunka, CEO, and John Docherty, president. The agreements offer LXRP and its shareholders the security of pursuing corporate growth within a seamless transition by providing management continuity. The renewal agreements are retroactive to January 1, 2019 (http://nnw.fm/J20Ew).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.0104, off by 0.94%, on 126,029 volume with 86 trades. The average volume for the last 3 months is 119,306 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Geyser Brands Inc. (TSXV: GYSR). Geyser Brands is a Health Canada-approved Licensed Producer based in Vancouver, BC, actively engaged in building a leading cannabis healthcare company with a diverse portfolio of products and brands in the lucrative health & wellness industry, including a range of products to promote pet health and wellness.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.82, off by 2.38%, on 6,000 volume with 1 trade. The average volume for the last 3 months is 8,000 and the stock's 52-week low/high is $0.61/$0.85.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) will lend its technological breakthrough in naturally produced, water-soluble cannabinoids to a joint venture with one of Canada's oldest and largest independent breweries to create a line of non‐alcoholic cannabis-infused beverages, anticipating the legalization of edible forms of cannabis in Canada later this year. Also today, CannabisNewsWire released a report on the company. To view the full publication, titled "Next Stage Cannabis Stocks in the Spotlight," please visit: http://cnw.fm/Sf6v5.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.575084, off by 7.99%, on 1,364,757 volume with 662 trades. The average volume for the last 3 months is 709,945 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the "Company") is excited to announce the signing of an agreement with Highmark Interactive to study the cognitive and functional neurological effects of cannabinoids through clinical research leveraging Highmark's industry-leading mobile software, EQ – Active Brain Tracking.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.52, off by 3.45%, on 9,337 volume with 9 trades. The average volume for the last 3 months is 24,023 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is airing its 'As Seen On TV' infomercial in the New York market. During the 60-second spot, entrepreneur Kevin Harrington, an original shark on Shark Tank, explains that ETST's full-spectrum cannabinoids can help with 'aches and pains' (http://nnw.fm/qOcc5).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.4999, off by 13.81%, on 75,486 volume with 33 trades. The average volume for the last 3 months is 32,983 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) was featured today in the 420 with CNW by CannabisNewsWire. Charles R. Broderick, a cannabis investor, has donated $9 million to his alma mater (Harvard and Massachusetts Institute of Technology-MIT) so that the two institutions can conduct research into the health effects of cannabis. The two academic institutions described the donation that they had received as the largest ever private funding into marijuana research.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.4443, off by 2.57%, on 127,773 volume with 95 trades. The average volume for the last 3 months is 476,490 and the stock's 52-week low/high is $0.417/$0.791.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF), a leader in 4G/LTE Push-To-Talk devices, is pleased to announce the commercial launch of both its 4G/LTE UR7 rugged handset and CP250 4G/LTE in-vehicle device with Partner Communications Company Ltd. (PTNL:NASDAQ). Also today, NetworkNewsWire released a report on the company detailing how SYATF announced its first purchase order from a Tier 1 U.S. cellular carrier for its flagship product, the Uniden UV350, in a news release issued early last month (http://nnw.fm/9HObH ). Details of the commercial launch of the Uniden UV350 in the U.S. will be announced shortly, according to Marc Seelenfreund, CEO of Siyata Mobile.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed the day's trading session at $0.326, off by 0.12%, on 37,500 volume with 12 trades. The average volume for the last 3 months is 54,784 and the stock's 52-week low/high is $0.254/$0.446.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based company Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is approaching three years of labor at the Irgon Dike, located in a region recognized for its spodumene and rare-element-bearing pegmatites. Typical hard rock mining effort takes three to five years to complete. To view the full article, visit: http://nnw.fm/Zq3ek.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.162, off by 2.88%, on 215,988 volume with 47 trades. The average volume for the last 3 months is 49,000 and the stock's 52-week low/high is $0.1155/$0.512.

Recent News

chart

City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

City View Green Holdings (CSE: CVGR) applauded Budd Hutt Inc.'s recent appointment of Craig Belcher as its new CEO (http://nnw.fm/aD95N). CVGR owns a 19.9 percent stake in its retail partner Budd Hutt, which is focusing on securing retail shelf space and obtaining distribution opportunities. To view the full article, visit: http://nnw.fm/TSlb5.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $0.115, even for the day, on 108,703 volume with 13 trades. The average volume for the last 3 months is 384,628 and the stock's 52-week low/high is $0.10/$0.465.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.